Search Weight Loss Topics:

Page 722«..1020..721722723724..730740..»

Home » Page 722

The Covid-19 pandemic has been challenging for everyone but for the nearly 21 million Americans battling addiction, it can be especially harmful.

For somebody in recovery, social isolation is a really slippery slope, said Scott Strode, a 2012 CNN Hero. It can often lead to the relapse.

Strode knows firsthand the reality of being in recovery. He was able to overcome his addiction to drugs and alcohol through sports and exercise. Encouraged by his success, in 2007 Strode started his non-profit, The Phoenix, to help others deal with their own addiction.

The organization has provided free athletic activities and a sober support community to more than 36,000 people across the United States.

When Covid-19 hit, the organization had to close its gyms and practice social distancing. But the non-profit found a new way to keep those connections and quickly pivoted to virtual programming.

Now, clients can log on to free virtual classes offered throughout the day everything from yoga and strength training to meditation and recovery meetings.

We hadnt done virtual programming before, but we pretty quickly learned that it allowed the Phoenix to offer programs to rural communities that we historically couldnt reach, Strode said.

The group now has people in recovery joining classes from all across the US, and four other countries. Theyve also been able to bring their programming into prisons nationwide by recording content that is then distributed to inmates.

I dont think were going to find some magic solution thats going to fix addiction in all of our communities, Strode said. I think we have to do it as a community and be there for each other letting people step into the pride and strength in their recovery can get us out of this.

CNNs Phil Mattingly recently joined a Phoenix class and spoke with Strode about his work. Below is an edited version of their conversation.

Phil Mattingly: What is it about these classes that you feel really resonates with people who are generally going through a pretty tough time?

Scott Strode: I always say that people come to the Phoenix for the workout, but they really stay for the friendships. When we face that greater adversity of that workout together, we build a bond. And in that bond, we find a place where we can support each other in our recovery journey. Often times we keep our struggles in the shadows, in this dark place of shame. Theres something really special about finding a community where you can just be open about all the challenges youve faced.

I think were all in recovery from something. For me, it just happens to be a substance use disorder. And when I find a community that accepts me and loves me for who I am, it just allows me to build different kinds of friendships.

Mattingly: Theres no silver lining or bright spots for many people over the last several months. Do you feel that whenever we get back to normal, this will end up almost being beneficial for the reach you were able to achieve?

Strode: I do. The idea that people can find recovery support through Phoenix now, really almost anytime, anywhere in the world is really exciting. Itll just allow it to reach so many more people because of this virtual platform. I didnt realize how much that was limiting our ability to get our programs to people who really needed it.

It just always lifts my heart to log into a Phoenix virtual class and meet somebody in recovery whos doing the workout in their basement somewhere in Tennessee, where we dont even have in-person programs, but they can come to the Phoenix anyway.

Mattingly: For somebody whos isolated at home right now, and either theyre in recovery or they have a loved one thats going through it right now, what would be your message to them?

Strode: If youre at home and youre either in recovery or youre even struggling with your addiction right now, just log into a Phoenix class. You just go to thephoenix.org, you pick a virtual class, you drop in. You can turn your camera off. You dont even have to talk if you dont want to. But check one out. And what youll realize is that theres individuals just like you that have either overcome their addiction or are trying to overcome it maybe the same way you are.

When youre having a tough day, you show up and usually by the end of the workout you forget what you were so stressed about in the first place. And its more just laughing and if we could, high fives and fist bumps but well have to wait till post-Covid for that.

Want to get involved? Check out the Phoenix website and see how to help.

Read the original here:
Virtual fitness classes allow this community battling addiction to gain strength during lockdown - KTVZ

Read More..

At first, the reality star, who shares three kids with Kourtney Kardashian, originally thought he had contracted Covid-19, saying, "Lately, I've just had no energy to do anything. I wake up and I'm just shot."

He went on, explaining, "I don't have the drive to get up and run around with my girlfriend and my kids. I just don't have the energy. I don't know if I'm getting old or I'm just not in great shape, but I just want to see if there's anything wrong with me."

"I'm definitely a drop nervous to do all these blood panels, because I've put this vessel through a lot of trauma, I'm not going to lie," he said. "I'm definitely scared, but if there's anything wrong with me, whatever is the best way to get my body functioning better is what I'm going to do."

He added that his body has taken a beating.

"I feel like there's definitely been some stress in my life," he continued. "Missing my parents, it's really hard. My life hasn't always been easy. I used to drink and party and go out a ton, so my body, it's been through some rough waters and taken some pretty bad beatings. I never thought that there was a possibility any of that stuff could affect me in the long run."

Disick has openly checked himself into rehab before.

When his blood results came back, Disick was told that his testosterone levels were "clinically low."

"I'm very thankful that there was nothing serious," he said. "It could be from a number of reasons, so my doctor suggested I meet with a nutritionist, who did a more detailed blood test to find out why my testosterone is so low and to see exactly what's working and what's not working on my body."

He has since changed his diet and is now taking supplements.

Read the original:
Scott Disick learns he has low testosterone, admits his body has been through 'some rough waters' - CNN

Read More..

The testosterone replacement therapy market is segmented on the lines of its product type and ingredient type. Based on product type the testosterone replacement therapy market is segmented into oral, implants, gums/ buccal adhesives, injections, patches and creams/ gels. The testosterone replacement therapy market is segmented on the lines of its ingredient type like testosterone, testosterone cypionate, testosterone enanthate, testosterone undecanoate and methyl testosterone. The testosterone replacement therapy marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Browse Full Report: https://www.marketresearchengine.com/upcommingreport/testosterone-replacement-therapy-market

Testosterone is responsible for the improvement of male sexual characteristics and this hormone formed by the testicles. It is also important to maintain various functions such as sexual function, bone growth, adequate levels of red blood cells, and a sense of well being and muscle bulk. Insufficient production of testosterone causes erectile dysfunction. Erectile dysfunction occurs due to decreased testosterone production to overcome this testosterone replacement therapy is used to improve the problem. Testosterone replacement therapy occurs in various forms containing its own set of advantages and hazards such as subdemal pellets, transdemal patches and injections. Testosterone replacement therapy also helps to recover symptoms of low testosterone. Low testosterone is caused due to age growth it generally lowers down after the mid 30s and further decreases accordingly to the age factor.

The scope of the report includes a detailed study of global and regional markets of Testosterone Replacement Therapy Market. The reasons given for variations in the growth of the industry in certain regions.

Global Testosterone Replacement Therapy Market is expected to exceed more than US$ 1.0 billion by 2024 at CAGR of 4% in the given forecast period.

The major driving factors of testosterone replacement therapy market are as follows:

Rise in incidence of testosterone deficiency.Increase in geriatric populace with high risk of testosterone deficiency.Increasing awareness about testosterone substitute therapy.

The restraining factors of testosterone replacement therapy market are as follows:

High possibility of side effects associated to testosterone replacement therapy.Patent expiry of key drugs and entry of generics.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include AbbVie, Inc., Allergan plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Mylan N.V., Novartis AG, and Pfizer, Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Testosterone Replacement Therapy Market has been segmented as below:

The Testosterone Replacement Therapy Market is Segmented on the lines of Product Type Analysis, Ingredient Type Analysis and Regional Analysis. By Product Type Analysis this market is segmented on the basis of Oral, Implants, Gums/Buccal Adhesives, Injections, Patches and Creams/Gels.

By Ingredient Type Analysis this market is segmented on the basis of Testosterone, Testosterone Cypionate, Testosterone Enanthate, Testosterone Undecanoate and Methyl Testosterone. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific, MEA and Rest of the World.

This report provides:

1) An overview of the global market for testosterone replacement therapy and related technologies.

2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.

3) Identifications of new market opportunities and targeted promotional plans for testosterone replacement therapy.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

Request Sample Report from here: https://www.marketresearchengine.com/upcommingreport/testosterone-replacement-therapy-market

Table of Contents

1 INTRODUCTION

2 Executive Summary

3 Global Testosterone Replacement Therapy Market Industry Analysis

4 North America Testosterone Replacement Therapy Market Analysis

5 Europe Testosterone Replacement Therapy Market Analysis

6 Asia Pacific Testosterone Replacement Therapy Market Analysis

7 Middle East and Africa (MEA) Testosterone Replacement Therapy Market Analysis

8 Latin America Testosterone Replacement Therapy Market Analysis

9 Global Testosterone Replacement Therapy Market, Country Snippets

9.1. Global Testosterone Replacement Therapy Market Revenue, by Country, (US$ Mn), 201420249.2. U.S. Testosterone Replacement Therapy Market Revenue, (US$ Mn), 201420249.3. Japan Testosterone Replacement Therapy Market Revenue, (US$ Mn), 201420249.4. Germany Testosterone Replacement Therapy Market Revenue, (US$ Mn), 201420249.5. U.K. Testosterone Replacement Therapy Market Revenue, (US$ Mn), 201420249.6. Canada Testosterone Replacement Therapy Market Revenue, (US$ Mn), 201420249.7. China Testosterone Replacement Therapy Market Revenue, (US$ Mn), 201420249.8. Brazil Testosterone Replacement Therapy Market Revenue, (US$ Mn), 201420249.9. Mexico Testosterone Replacement Therapy Market Revenue, (US$ Mn), 201420249.10. United Arab Emirates (UAE) Testosterone Replacement Therapy Market Revenue, (US$ Mn), 20142024

10 Company Profiles

10.1. AbbVie, Inc.

10.2. Allergan plc

10.3. Bayer AG

10.4. Endo Pharmaceuticals, Inc.

10.5. Eli Lilly and Company

10.6. Kyowa Kirin International plc

10.7. Mylan N.V.

10.8. Novartis AG

10.9. Pfizer, Inc.

Other Related Market Research Reports:

Topical Drug Delivery Market Size, Industry Share, Approaches and Forecast By 2022

Tuberculosis Testing Market is Expected to Get US$ 2600 Million By 2022

Urinary Tract Infection Treatment Market is Expected to Grow US$ 10 Billion By 2024

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: [emailprotected]

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

Read more here:
Testosterone Replacement Therapy Market Industry Development Trends & Competitive Analysis by Leading Industry Players - The Daily Chronicle

Read More..

Covid-19 could lower testosterone levels and libido in men - heres what the new study found(Photo: Shutterstock)

A new study has revealed that men who contracted Covid-19 have their testosterone levels lowered by 30 per cent, on average.

Even two thirds of men who showed no symptoms reported a loss of libido.

Researchers in Turkey analysed levels of sex hormone in 232 men who were hospitalised after they tested positive for Covid-19.

What is hypogonadism?

More than half (51 per cent) of the men had developed a condition called hypogonadism, meaning their bodies did not produce enough testosterone.

On average participants levels were drained by 30 per cent post-infection, to borderline unhealthy levels.

Academics from the University of Mersin who ran the study claim there is a direct correlation between severe illness and lower testosterone levels.

Lead author, Professor Selahittin ayan (a urologist at the university) said, In our study, the mean total testosterone decreased, as the severity of the Covid-19 increased.

The mean total testosterone level was significantly lower in the ICU group than in the asymptomatic group.

In addition, the mean total testosterone level was significantly lower in the ICU group than in the standard care group.

Why do men need testosterone?

Testosterone is key to the development of sex organs and muscle growth. The hormone also helps regulate the bodys immune responses, including fighting off viral infections.

Low levels have been linked to an increased risk of dying from the flu, as well as inflammation, heart disease and high blood pressure.

A healthy level of testosterone is usually considered to be above 300 nanograms per decilitre (ng/dl).

Results in the study showed that patients saw their levels drop by a third, on average, from 458 ng/dl to 315 ng/dl.

Professor ayan describes the uses of the hormone saying, Testosterone is associated with the immune system of respiratory organs, and low levels of testosterone might increase the risk of respiratory infections.

Low testosterone is also associated with infection-related hospitalisation and all-cause mortality in male in ICU patients, so testosterone treatment may also have benefits beyond improving outcomes for Covid-19.

See the original post here:
Covid-19 could lower testosterone levels and libido in men - heres what the new study found - Shields Gazette

Read More..

Recently published in Nature Magazines Scientific Reports, Dr. Lee Gettler, an associate professor of anthropology at Notre Dame, has completed a new study which links testosterone levels in fathers with their broader cultural settings.

Gettler said that he became interested in his research when he met Dr. Adam Boyette, who is now a senior researcher at the Max Planck Institute for Evolutionary Anthropology, at a conference put on by the Jacobs Foundation.

[The Jacobs Foundation] put together a conference that was specifically bringing together a really large group of scholars who specifically studied fathers from diverse perspectives psychology, sociology, neuroscience, anthropology to try to get all these people in the same room to talk about how we can begin to kind of best understand the way that fathers impact human children, Gettler said.

A father from the BaYaka tribe poses for a photo with his young sonin the northern Republic of Congo, where Boyette did his field work.

Boyette did his dissertation research in a remote region in northern Republic of the Congo accessible by a weeklong journey from the capital city of Brazzaville. There he studied the BaYaka and Bondongo people who live a very different lifestyle than one were used to. Although located in the same village, the two tribes have their own distinct cultures. The BaYaka people are a more egalitarian society, focused on cooperative living, whereas the Bondongo people are fisher-farmers whose society is hierarchical and status-based.

Boyette noted that the differences between these two communities who live in such close conjunction is really what drew their study to this remote corner of the world.

Our interest was to work with both groups and try to understand differences and look to see if there were differences in fathering that are related to cultural differences, including things like variation in the family systems and what fathers do in the community, Boyette said.

They hypothesized that the testosterone levels of the BaYaka men and Bondongo men were different. Testosterone, a hormone which has been shown to decrease in men when entering fatherhood in some cultural settings, can be associated with physical strength and aggression. Gettlers team hypothesized that since the BaYaka fathers place more emphasis on community and generosity, their testosterone levels will be lower than the Bondongo fathers, who are valued more for their strength and being a good resource provider.

When the researches had an opportunity to collaborate via funding from the Jacobs Foundation, Boyette said that he and Gettler jumped at the chance.

[The Jacobs Foundation] offered us this opportunity to apply for funding to work on projects together, Boyette said. It was a really fantastic opportunity and Lee and I right away saw a really good opportunity to collaborate because we both had different skill sets that we recognized would work well together.

Before the two could conduct any formal research, they had to connect with the communities and get settled.

The first summer of our grant, [Boyette] went to field site and just basically was hanging out to gain trust with the communities to talk to them about Heres what were interested in, were interested in learning about your communities and heres what we would do, Gettler said. [Boyette was] getting permission from the communities, particularly the elders and the leadership councils in the community, to make sure that they were that it was acceptable to them, ethically, that we do this work.

Boyette said that the work was challenging, and it would not have been possible without the help of others who blazed the trail for him.

Another challenge faced by the team was how to transport their materials. Gettler explained that this was an especially difficult project because they needed to transport large liquid nitrogen jugs to store saliva samples containing information about testosterone from the BaYaka and Bondongo men.

If we look at testosterone in saliva, it correlates really strongly to what is circulating in the blood in the body, but its obviously much less invasive than collecting blood so thats the benefit, Gettler mentioned. Part of the reason that there are few studies in this kind of relatively remote setting is because of the challenges of dealing with the biological markers.

Boyette explained that they had to modify their travel plans in order to transport the materials to the remote communities because the canisters of liquid nitrogen need to be closely monitored at all times to prevent spillage.

The researchers also struggled with the problem of how to quantify how the different cultures viewed fatherhood and how to decide who were the good fathers.

Gettler explained that the team conducted a series of long interviews with the villagers to get a sense of the values that were sought after in a good father.

[Boyette and his team] spent a lot of time doing semi-structured qualitative interviewswed call that data ethnography, Gettler said. Our real goal was to try to understand how these communities are defining what a good father is and then can we find a way to operationalize that to get at whether good fathers, based on local values, have healthier kids.

Once they had sorted out the cultural ideas of fatherhood, the researchers had each respective father rank each other on the main values pointed out by each community. The questions that the fathers ranked each other by varied between the BaYaka and Bondongo groups: The BaYaka cultural ranked good fathers based on how they shared resources, how hard they worked, whether they had any spousal arguments, whether their children were healthy and if they contributed to community teaching. On the other hand, the Bondongo people ranked good fathers based on fishing/hunting abilities, how big their gardens were, if they traveled to get commercial goods for the community, if they had healthy children and if they contributed to social education.

Boyette said that the different questions actually revealed a lot about the communities. He explained that they found that the Bondongo fathers were actually sorted into two groups: one of the groups of fathers focused more on the hard, laborious chores of fishing and hunting, and the other group focused on the teaching of children and staying closer to the community. As Boyette and Gettler expected, the group of Bondongo fathers that focused on the strength intensive tasks had higher levels of testosterone than the group that focused more on the children. With the BaYaka tribe who are more focused on cooperative communities, the researched noted lower levels of testosterone in men who were ranked as better fathers.

The team also noted a correlation between testosterone levels and martial arguments. They found that fathers in both communities who were rated as having more martial conflicts had higher testosterone levels.

Gettler and Boyette both agree that their study has impacts outside the remote village in the Republic of Congo. Boyette said that he believes this study shows us that there is not just one way to be a great father.

Theres not one good way that men should be contributing to their families and we have to recognize that men see themselves as coming from particular different cultural backgrounds and that these may also suit their biology better or are promoted by their biology in different ways, Boyette said. We should be able to welcome various ways of being fathers and different ways of contributing to the child development and supporting.

Here is the original post:
Notre Dame professor publishes study with new insights on fatherhood - Observer Online

Read More..

In the last few years there has been more research around sexual function during the menopause transition in areas such as low libido or pain during intercourse, but very little specifically focused on how important sex is to women during this time, says Holly N. Thomas, MD, assistant professor of medicine at the University of Pittsburgh in Pennsylvania. Dr. Thomas is the lead author of research presented on the topic of the importance of sex in women as they age at the 2020 Virtual Annual Meeting of The North American Menopause Society (NAMS), which opened on September 28, 2020.

We were interested in looking at how womens ratings of how important sex was to them changes or stays the same as they move through the menopausal transition, says Thomas.

To find out the answer, investigators studied a total of 3,257 women from The Study of Womens Health Across the Nation (SWAN), all of whom completed 14 evaluations over 15 years. Visits included interviews, questionnaires, blood draws, and biometric measures such as body mass index (BMI), blood pressure levels, hormone levels, and depression symptoms.

RELATED: 10 Symptoms of Menopause and Perimenopause

Women were asked to rate how important sex was to them with the choices of not at all, not very, moderately, quite, or extremely.

Rather than look at averages of the women over time, investigators looked at trajectories within the cohort. This analysis technique allowed us to see if there are unique pathways that women can follow, explains Thomas.

If you just looked at averages of the group as a whole, it would look like how important sex is to women would go down for everyone, but what we actually found three distinct pathways women commonly follow when it comes to how much they value sex as they get older, she says.

RELATED: Masturbation 101: A Guide to Solo Sex for Women

For the largest group, about 45 percent of the women, sex did become less important to them as they went through their forties and fifties and early sixties, says Thomas. For 27 percent of the women, sex remained highly important to them throughout midlife, and for 28 percent of the women sex was not very important to them throughout the whole duration of midlife, from forties to sixties.

Its important to recognize not all women are going to follow the same pathway when it comes to sex at midlife, each woman has her own unique experience, says Thomas.

There were a few trends that Thomas and her team noticed.

These results show that its not necessarily true that sex becomes less important to all women at midlife and that its just an inevitable fact of aging, says Thomas.

RELATED: Menopause and Depression Is Strongly Linked

My takeaway was that we need to be more routinely asking women in midlife about their sexual function and whether there are barriers such as having pain during intercourse or if theyre having problems with low sexual desire thats bothering them, says Stephanie Faubion, MD, director of the Mayo Clinic Center for Womens Health in Rochester, Minnesota, and medical director of NAMS.

Sexual function is usually under addressed in women in general but certainly in women beyond menopause, adds Dr. Faubion.

RELATED:Sex Drug for Women Stirs Up Controversy in Medical Community

In general, women who have a good sex life before menopause have a good sex life after menopause, she says. This research indicates that if sex is important to a woman before menopause, its important after.

RELATED: Sexual Dysfunction in Some Women Can Occur Years Before Menopause, Study Says

Keep in mind that sex doesnt look the same with aging, says Faubion. We have to modify our expectations about sexual functioning as we get older. Sex may not be always be penis and vagina sex; I have that conversation often with my patients, she says.

As peoples bodies and health changes, including medical illnesses that can be experienced by both men and women, we may need to modify what we are doing, but nonetheless, sexual intimacy remains important to all people for as long as they live, says Faubion.

RELATED: What Is the Role of Intimacy and Sex in Overall Health?

About 30 percent or so of women in the United States report low libido or sex drive, and about 10 percent report being bothered or distressed by it, Brooke Faught, doctor of nursing practice and board-certified women's healthcare nurse practitioner, who is clinical director of the Womens Institute for Sexual Health in Nashville, Tennessee. Dr. Faught presented on sexual health, libido, and testosterone at the NAMS 2020 conference.

Having a low sex drive isnt automatically a reason for treatment; hypoactive sexual desire disorder (HSDD) is when women have a low libido and are bothered or distressed by it. If the patient isnt directly impacted or bothered by it and its not impacting their daily function, its not a true diagnosable condition, says Faught.

RELATED: The Facts About Sexual Desire Disorder (Low Libido) In Women and Men

Even when they are bothered by a lack of desire, many women put up with it rather than seek treatment; they think its a normal part of aging or something they should just deal with, she says.

One barrier that stands in the way of treating HSDD is the lack of an U.S. Food and Drug Administration (FDA)approved testosterone for women with HSDD, even though there is quite a bit of published research on how and when to use it, says Faught.

Faubion agrees, saying Testosterone is fairly well studied for sexual health in women and is effective in almost all areas of sexual function.

RELATED: Women Need Testosterone Formulation for Low Libido

The barrier that exists isnt lack of science or lack of interest, its the FDA, says Faught. The FDA has asked for more long-term data for using testosterone in hypoactive sexual desire disorder (HSDD) in women, potentially up to five years [worth], she says.

A study that would fulfill the FDAs request seems to be cost prohibitive for pharmaceutical companies, says Faught. I dont know of any specific product that is on the cusp of getting approval or seeking approval, which is unfortunate and frustrating, she adds.

There are options and guidance for how to use testosterone products for HSDD, says Faught. In 2018, the International Society for the Study of Womens Sexual Health (ISSWSH) published a process of care (POC) for the diagnosis and management of hypoactive sexual desire disorder (HSDD) in pre- and postmenopausal women, including guidelines for prescribing testosterone in postmenopausal women with HSDD.

A global consensus statement that was endorsed by several international medical societies including The International Menopause Society, The Endocrine Society, and the NAMS was published in The Journal of Clinical Endocrinology & Metabolism in October 2019. The statements purpose is to provide clear guidance on which women may benefit from testosterone therapy, as well as any potential risks.

The issue is that treating off-label can carry additional risk and expense for patients, says Faught. If I prescribe a testosterone product thats intended for men, I can prescribe it at a lower dose as is necessary, but because it isnt FDA approved for this use, usually insurance wont cover it. That could mean a cost of anywhere from $300 to $500, she says.

Compounding testosterone, a process where a pharmacist specifically makes the product from scratch may be cheaper, but then there is increased potential for human error as well as a lack of regulations, says Faught.

Probably the main reason there is no FDA-approved testosterone product for HSDD is that theres a lack of long-term safety data, says Faubion. For example, we dont know breast cancer risk, we dont know cardiovascular risk, she says.

The cardiovascular risk appears to be less of concern for women than it is for men taking testosterone, but the bigger question is breast cancer risk over time, says Faubion. This is because testosterone converts to estrogen inside the body, and so there is a question on whether that increases breast cancer risk, she says.

Ive used it in my practice and its effective for women, says Faubion. Yes, we still have questions about long-term safety and long-term efficacy, but for short-term efficacy and short-term safety, we have pretty convincing data; I think ultimately it probably will be approved for use in women.

RELATED:Menopause and Sleep News: NAMS 2020 Addresses 5 Key Issues;

Hot Flash Treatment News: 4 Takeaways From NAMS 2020

Read more:
Sex Life, Sex Drive, and Menopause: News from NAMS 2020 - Everyday Health

Read More..

LOS ANGELES, United States: QY Research has recently published a research report titled, Global Testosterone Replacement Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026. This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Testosterone Replacement Therapy market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Testosterone Replacement Therapy market.

The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Testosterone Replacement Therapy market.

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Testosterone Replacement Therapy market.

Key questions answered in the report:

TOC

1 Study Coverage1.1 Testosterone Replacement Therapy Product Introduction1.2 Market by Type1.2.1 Global Testosterone Replacement Therapy Market Size Growth Rate by Type1.2.2 Gels1.2.3 Injections1.2.4 Patches1.2.5 Other1.3 Market by Application1.3.1 Global Testosterone Replacement Therapy Market Size Growth Rate by Application1.3.2 Hospitals1.3.3 Clinics1.3.4 Others1.4 Study Objectives1.5 Years Considered 2 Executive Summary2.1 Global Testosterone Replacement Therapy Market Size Estimates and Forecasts2.1.1 Global Testosterone Replacement Therapy Revenue 2015-20262.1.2 Global Testosterone Replacement Therapy Sales 2015-20262.2 Testosterone Replacement Therapy Market Size by Region: 2020 Versus 20262.3 Testosterone Replacement Therapy Sales by Region (2015-2026)2.3.1 Global Testosterone Replacement Therapy Sales by Region: 2015-20202.3.2 Global Testosterone Replacement Therapy Sales Forecast by Region (2021-2026)2.3.3 Global Testosterone Replacement Therapy Sales Market Share by Region (2015-2026)2.4 Testosterone Replacement Therapy Market Estimates and Projections by Region (2021-2026)2.4.1 Global Testosterone Replacement Therapy Revenue by Region: 2015-20202.4.2 Global Testosterone Replacement Therapy Revenue Forecast by Region (2021-2026)2.4.3 Global Testosterone Replacement Therapy Revenue Market Share by Region (2015-2026) 3 Global Testosterone Replacement Therapy by Manufacturers3.1 Global Top Testosterone Replacement Therapy Manufacturers by Sales3.1.1 Global Testosterone Replacement Therapy Sales by Manufacturer (2015-2020)3.1.2 Global Testosterone Replacement Therapy Sales Market Share by Manufacturer (2015-2019)3.2 Global Top Testosterone Replacement Therapy Manufacturers by Revenue3.2.1 Global Testosterone Replacement Therapy Revenue by Manufacturer (2015-2020)3.2.2 Global Testosterone Replacement Therapy Revenue Share by Manufacturer (2015-2020)3.3 Global Testosterone Replacement Therapy Price by Manufacturer (2015-2020)3.4 Competitive Landscape3.4.1 Key Testosterone Replacement Therapy Manufacturers Covered: Ranking by Revenue3.4.2 Global Testosterone Replacement Therapy Market Concentration Ratio (CR5 and HHI) & (2015-2020)3.4.3 Global Testosterone Replacement Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.5 Global Testosterone Replacement Therapy Manufacturing Base Distribution, Product Type3.5.1 Testosterone Replacement Therapy Manufacturers Manufacturing Base Distribution, Headquarters3.5.2 Manufacturers Testosterone Replacement Therapy Product Type3.5.3 Date of International Manufacturers Enter into Testosterone Replacement Therapy Market3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Company Profiles4.1 AbbVie4.1.1 AbbVie Corporation Information4.1.2 AbbVie Description, Business Overview4.1.3 AbbVie Testosterone Replacement Therapy Products Offered4.1.4 AbbVie Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.1.5 AbbVie Testosterone Replacement Therapy Revenue by Product4.1.6 AbbVie Testosterone Replacement Therapy Revenue by Application4.1.7 AbbVie Testosterone Replacement Therapy Revenue by Geographic Area4.1.8 AbbVie Testosterone Replacement Therapy Revenue by Sales Channel4.1.9 AbbVie Recent Development4.2 Endo International4.2.1 Endo International Corporation Information4.2.2 Endo International Description, Business Overview4.2.3 Endo International Testosterone Replacement Therapy Products Offered4.2.4 Endo International Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.2.5 Endo International Testosterone Replacement Therapy Revenue by Product4.2.6 Endo International Testosterone Replacement Therapy Revenue by Application4.2.7 Endo International Testosterone Replacement Therapy Revenue by Geographic Area4.2.8 Endo International Testosterone Replacement Therapy Revenue by Sales Channel4.2.9 Endo International Recent Development4.3 Eli lilly4.3.1 Eli lilly Corporation Information4.3.2 Eli lilly Description, Business Overview4.3.3 Eli lilly Testosterone Replacement Therapy Products Offered4.3.4 Eli lilly Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.3.5 Eli lilly Testosterone Replacement Therapy Revenue by Product4.3.6 Eli lilly Testosterone Replacement Therapy Revenue by Application4.3.7 Eli lilly Testosterone Replacement Therapy Revenue by Geographic Area4.3.8 Eli lilly Testosterone Replacement Therapy Revenue by Sales Channel4.3.9 Eli lilly Recent Development4.4 Pfizer4.4.1 Pfizer Corporation Information4.4.2 Pfizer Description, Business Overview4.4.3 Pfizer Testosterone Replacement Therapy Products Offered4.4.4 Pfizer Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.4.5 Pfizer Testosterone Replacement Therapy Revenue by Product4.4.6 Pfizer Testosterone Replacement Therapy Revenue by Application4.4.7 Pfizer Testosterone Replacement Therapy Revenue by Geographic Area4.4.8 Pfizer Testosterone Replacement Therapy Revenue by Sales Channel4.4.9 Pfizer Recent Development4.5 Actavis (Allergan)4.5.1 Actavis (Allergan) Corporation Information4.5.2 Actavis (Allergan) Description, Business Overview4.5.3 Actavis (Allergan) Testosterone Replacement Therapy Products Offered4.5.4 Actavis (Allergan) Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.5.5 Actavis (Allergan) Testosterone Replacement Therapy Revenue by Product4.5.6 Actavis (Allergan) Testosterone Replacement Therapy Revenue by Application4.5.7 Actavis (Allergan) Testosterone Replacement Therapy Revenue by Geographic Area4.5.8 Actavis (Allergan) Testosterone Replacement Therapy Revenue by Sales Channel4.5.9 Actavis (Allergan) Recent Development4.6 Bayer4.6.1 Bayer Corporation Information4.6.2 Bayer Description, Business Overview4.6.3 Bayer Testosterone Replacement Therapy Products Offered4.6.4 Bayer Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.6.5 Bayer Testosterone Replacement Therapy Revenue by Product4.6.6 Bayer Testosterone Replacement Therapy Revenue by Application4.6.7 Bayer Testosterone Replacement Therapy Revenue by Geographic Area4.6.8 Bayer Recent Development4.7 Novartis4.7.1 Novartis Corporation Information4.7.2 Novartis Description, Business Overview4.7.3 Novartis Testosterone Replacement Therapy Products Offered4.7.4 Novartis Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.7.5 Novartis Testosterone Replacement Therapy Revenue by Product4.7.6 Novartis Testosterone Replacement Therapy Revenue by Application4.7.7 Novartis Testosterone Replacement Therapy Revenue by Geographic Area4.7.8 Novartis Recent Development4.8 Teva4.8.1 Teva Corporation Information4.8.2 Teva Description, Business Overview4.8.3 Teva Testosterone Replacement Therapy Products Offered4.8.4 Teva Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.8.5 Teva Testosterone Replacement Therapy Revenue by Product4.8.6 Teva Testosterone Replacement Therapy Revenue by Application4.8.7 Teva Testosterone Replacement Therapy Revenue by Geographic Area4.8.8 Teva Recent Development4.9 Mylan4.9.1 Mylan Corporation Information4.9.2 Mylan Description, Business Overview4.9.3 Mylan Testosterone Replacement Therapy Products Offered4.9.4 Mylan Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.9.5 Mylan Testosterone Replacement Therapy Revenue by Product4.9.6 Mylan Testosterone Replacement Therapy Revenue by Application4.9.7 Mylan Testosterone Replacement Therapy Revenue by Geographic Area4.9.8 Mylan Recent Development4.10 Upsher-Smith4.10.1 Upsher-Smith Corporation Information4.10.2 Upsher-Smith Description, Business Overview4.10.3 Upsher-Smith Testosterone Replacement Therapy Products Offered4.10.4 Upsher-Smith Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.10.5 Upsher-Smith Testosterone Replacement Therapy Revenue by Product4.10.6 Upsher-Smith Testosterone Replacement Therapy Revenue by Application4.10.7 Upsher-Smith Testosterone Replacement Therapy Revenue by Geographic Area4.10.8 Upsher-Smith Recent Development4.11 Ferring Pharmaceuticals4.11.1 Ferring Pharmaceuticals Corporation Information4.11.2 Ferring Pharmaceuticals Description, Business Overview4.11.3 Ferring Pharmaceuticals Testosterone Replacement Therapy Products Offered4.11.4 Ferring Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.11.5 Ferring Pharmaceuticals Testosterone Replacement Therapy Revenue by Product4.11.6 Ferring Pharmaceuticals Testosterone Replacement Therapy Revenue by Application4.11.7 Ferring Pharmaceuticals Testosterone Replacement Therapy Revenue by Geographic Area4.11.8 Ferring Pharmaceuticals Recent Development4.12 Kyowa Kirin4.12.1 Kyowa Kirin Corporation Information4.12.2 Kyowa Kirin Description, Business Overview4.12.3 Kyowa Kirin Testosterone Replacement Therapy Products Offered4.12.4 Kyowa Kirin Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.12.5 Kyowa Kirin Testosterone Replacement Therapy Revenue by Product4.12.6 Kyowa Kirin Testosterone Replacement Therapy Revenue by Application4.12.7 Kyowa Kirin Testosterone Replacement Therapy Revenue by Geographic Area4.12.8 Kyowa Kirin Recent Development4.13 Acerus Pharmaceuticals4.13.1 Acerus Pharmaceuticals Corporation Information4.13.2 Acerus Pharmaceuticals Description, Business Overview4.13.3 Acerus Pharmaceuticals Testosterone Replacement Therapy Products Offered4.13.4 Acerus Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2015-2020)4.13.5 Acerus Pharmaceuticals Testosterone Replacement Therapy Revenue by Product4.13.6 Acerus Pharmaceuticals Testosterone Replacement Therapy Revenue by Application4.13.7 Acerus Pharmaceuticals Testosterone Replacement Therapy Revenue by Geographic Area4.13.8 Acerus Pharmaceuticals Recent Development 5 Breakdown Data by Type5.1 Global Testosterone Replacement Therapy Sales by Type (2015-2026)5.1.1 Global Testosterone Replacement Therapy Sales by Type (2015-2020)5.1.2 Global Testosterone Replacement Therapy Sales Forecast by Type (2021-2026)5.1.3 Global Testosterone Replacement Therapy Sales Market Share by Type (2015-2026)5.2 Global Testosterone Replacement Therapy Revenue Forecast by Type (2015-2026)5.2.1 Global Testosterone Replacement Therapy Revenue by Type (2015-2020)5.2.2 Global Testosterone Replacement Therapy Revenue Forecast by Type (2021-2026)5.2.3 Global Testosterone Replacement Therapy Revenue Market Share by Type (2015-2026)5.3 Testosterone Replacement Therapy Average Selling Price (ASP) by Type (2015-2026) 6 Breakdown Data by Application6.1 Global Testosterone Replacement Therapy Sales by Application (2015-2026)6.1.1 Global Testosterone Replacement Therapy Sales by Application (2015-2020)6.1.2 Global Testosterone Replacement Therapy Sales Forecast by Application (2021-2026)6.1.3 Global Testosterone Replacement Therapy Sales Market Share by Application (2015-2026)6.2 Global Testosterone Replacement Therapy Revenue Forecast by Application (2015-2026)6.2.1 Global Testosterone Replacement Therapy Revenue by Application (2015-2020)6.2.2 Global Testosterone Replacement Therapy Revenue Forecast by Application (2021-2026)6.2.3 Global Testosterone Replacement Therapy Revenue Market Share by Application (2015-2026)6.3 Testosterone Replacement Therapy Average Selling Price (ASP) by Application (2015-2026) 7 North America7.1 North America Testosterone Replacement Therapy Market Size YoY Growth 2015-20267.2 North America Testosterone Replacement Therapy Market Facts & Figures by Country7.2.1 North America Testosterone Replacement Therapy Sales by Country (2015-2026)7.2.2 North America Testosterone Replacement Therapy Revenue by Country (2015-2026)7.3 North America Testosterone Replacement Therapy Sales by Type7.4 North America Testosterone Replacement Therapy Sales by Application 8 Asia-Pacific8.1 Asia-Pacific Testosterone Replacement Therapy Market Size YoY Growth 2015-20268.2 Asia-Pacific Testosterone Replacement Therapy Market Facts & Figures by Region8.2.1 Asia-Pacific Testosterone Replacement Therapy Sales by Region (2015-2026)8.2.2 Asia-Pacific Testosterone Replacement Therapy Revenue by Region (2015-2026)8.3 Asia-Pacific Testosterone Replacement Therapy Sales by Type8.4 Asia-Pacific Testosterone Replacement Therapy Sales by Application 9 Europe9.1 Europe Testosterone Replacement Therapy Market Size YoY Growth 2015-20269.2 Europe Testosterone Replacement Therapy Market Facts & Figures by Country9.2.1 Europe Testosterone Replacement Therapy Sales by Country (2015-2026)9.2.2 Europe Testosterone Replacement Therapy Revenue by Country (2015-2026)9.3 Europe Testosterone Replacement Therapy Sales by Type9.4 Europe Testosterone Replacement Therapy Sales by Application 10 Latin America10.1 Latin America Testosterone Replacement Therapy Market Size YoY Growth 2015-202610.2 Latin America Testosterone Replacement Therapy Market Facts & Figures by Country10.2.1 Latin America Testosterone Replacement Therapy Sales by Country (2015-2026)10.2.2 Latin America Testosterone Replacement Therapy Revenue by Country (2015-2026)10.3 Latin America Testosterone Replacement Therapy Sales by Type10.4 Latin America Testosterone Replacement Therapy Sales by Application 11 Middle East and Africa11.1 Middle East and Africa Testosterone Replacement Therapy Market Size YoY Growth 2015-202611.2 Middle East and Africa Testosterone Replacement Therapy Market Facts & Figures by Country11.2.1 Middle East and Africa Testosterone Replacement Therapy Sales by Country (2015-2026)11.2.2 Middle East and Africa Testosterone Replacement Therapy Revenue by Country (2015-2026)11.3 Middle East and Africa Testosterone Replacement Therapy Sales by Type11.4 Middle East and Africa Testosterone Replacement Therapy Sales by Application 12 Supply Chain and Sales Channel Analysis12.1 Testosterone Replacement Therapy Supply Chain Analysis12.2 Testosterone Replacement Therapy Key Raw Materials and Upstream Suppliers12.3 Testosterone Replacement Therapy Clients Analysis12.4 Testosterone Replacement Therapy Sales Channel and Sales Model Analysis12.4.1 Testosterone Replacement Therapy Distribution Channel Analysis: Indirect Sales VS Direct Sales12.4.2 Testosterone Replacement Therapy Distribution Channel Analysis: Online Sales VS Offline Sales12.4.3 Testosterone Replacement Therapy Distributors 13 Market Dynamics13.1 Testosterone Replacement Therapy Market Drivers13.2 Testosterone Replacement Therapy Market Opportunities13.3 Testosterone Replacement Therapy Market Challenges13.4 Testosterone Replacement Therapy Market Restraints13.5 Porters Five Forces Analysis 14 Research Findings and Conclusion 15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Author Details15.3 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Original post:
Testosterone Replacement Therapy Market size was US$ 1665.5 million and it is expected to reach US$ 1238.2 million by the end of 2026, with a CAGR of...

Read More..

By: Lifestyle Desk | New Delhi | Updated: October 5, 2020 8:19:02 amThe actor passed away due to kidney failure caused by keto diet. (Photo: Misti Mukherjee/Facebook)

While dieting is a common practice these days, death due to a certain kind of diet was previously unheard of. Until it was learnt that actor Misti Mukherjees demise was because of kidney failure caused by the keto diet which has gained a lot of popularity in the recent past.

A statement made by her family claims the actor who is survived by her parents and brother was in a lot of pain.

ALSO READ | US man dies of excessive liquorice or mulethi: Know how much to have

Mukherjees passing raises a series of questions on the health risks of dieting. As such, it becomes important to understand the reasons that may have led to her health deterioration and subsequent death.

What is the keto diet?

It entails the consumption of high amounts of fat with adequate amounts of protein and fewer carbohydrates. Also known as KD, this diet is particularly followed by diabetics because it can cause massive reductions in blood sugar and insulin levels.

Nutritionist Ruchi Sharma, however, points out the keto diet is primarily used to help reduce seizures in childrens suffering from epilepsy. Avoiding carbs and substituting it with proteins and fats has become a leading dogma among those who are looking to lose weight quickly, she says.

ALSO READ | Cheat day during Keto diet may damage blood vessels

How does a keto diet lead to kidney failure?

Dr Pradip Shah, Consultant Physician at Fortis Hospital, Mulund tells indianexpress.com: This is a rare case and usually happens when there is a pre-existing disease and someone then continues to follow the diet. Keto diet requires one to eat high amounts of fat alongside proteins and fewer carbohydrates. When a person continues to do this, it affects the kidneys.

Adding to it, Sharma says: We see people doing keto with processed cheese and butter, which when done for prolonged periods of time, can increase the risk of high cholesterol; also high protein can put pressure on kidneys. When we eat a high amount of protein while doing a keto it may overload the kidney.

Drastically reducing carbohydrates and overloading the kidneys can lead to some problem in elimination of all the waste products of protein metabolism.

Dr Shah suggests a person should follow the diet only for six months. If they continue, they need to take a break for 1-2 months at least, and then get on with the same.

ALSO READ | Keto diet supplements may help diabetics, says study

Are there any other diets that can lead to organ failure?

Dr Shah says any diet which contains consuming fewer carbohydrates for a longer period of time can cause failure. However, another specific diet is the paleo diet also known as the stone-age diet. It is a modern fad diet which requires one to mirror the kind of diet followed during the Paleolithic era.

He also mentions that consuming sugary beverages such as aerated drinks or soft drinks and highly-processed food frequently, can harm the kidneys. Not only that, preservatives in food items contain phosphorous and sodium, which affect the kidney to a larger extent, he warns.

While many different diseases, toxins and drugs can lead to renal failures, by far the most common causes of kidney diseases are diabetes and high blood pressure which can damage the delicate blood vessels and tissues of the kidneys. When these two are not addressed, chronic kidney disease and ultimately kidney failure can be the result, says Sharma.

She suggests rather than following a keto diet, we can opt for a well-formulated low-carb diet, which is not typically high in protein and can help in reducing as well as maintaining weight loss.

Choose foods that are healthy for your heart and your entire body such as fresh fruits, a rainbow of vegetables, whole grains, low fat or fat-free dairy products. Make physical activity a part of your routine, as sweating helps in removing toxins as well, says the nutritionist.

ALSO READ | Keto diet may bring health benefits in short term: Study

For more lifestyle news, follow us: Twitter:lifestyle_ie|Facebook:IE Lifestyle| Instagram:ie_lifestyle

The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Lifestyle News, download Indian Express App.

IE Online Media Services Pvt Ltd

Read more here:
Death by diet: How risky is keto? Experts answer - The Indian Express

Read More..

Although it has been around for some time, intermittent fasting remains one of the most popular energy restriction diets today.

As the name suggests, it involves following a precise schedule with intervals of fasting and specific times in the day when you are allowed to eat. Often adopted by people aiming to lose weight, if misapplied, the method may in fact have the opposite effect, warns Parisian physician nutrition specialist Dr Arnaud Cocaul.

A 16-hour stretch of not eating, preferably in the morning or evening, followed by an eight-hour period in which you can have meals and even the occasional snack: this is a typical schedule for intermittent fasting, an energy restriction diet that has been shown to offer numerous benefits including an enhanced immune system and a faster metabolism.

Not surprisingly the trend for this method has attracted increasing numbers of people eager to lose weight, not least because it is reputed to encourage feelings of satiety. However, care must be taken to carefully apply the guidelines, points out physician nutrition specialist Arnaud Cocaul, who summarises the right reflexes to adopt and pitfalls to be avoided.

Is intermittent fasting suitable for everyone?

Dr. Arnaud Cocaul: Actually, no. Some people will find it easy not to eat for 16 hours, while others will quickly have attacks of the munchies, or even suffer from vertigo or nausea. In the latter case, it is important to heed your body and not overdo it, or at least to limit the amount of time you spend on the diet.

People who have a more or less normal weight should be especially careful. Fasting can pave the way for all sorts of eating disorders. There are less radical options to try: just eating more slowly, for example, is one of these.

Fewer kilos on the scales does not necessarily translate into less body fat

Dr. Cocaul: No, it does not. The distinction between losing fat and losing muscle is an important one. People whose bodies do not tolerate being deprived of food may find that they lose muscle mass before shedding fat.

It follows that when they lose weight they are first and foremost losing muscle, and this can result in very strong urges for food, which can actually result in weight gain.

Are there other risks associated with intermittent fasting?

Dr. Cocaul: Strictly speaking they arent really risks, because not eating for a limited period is not in itself a problem as long as you have adequate nutrition. That is where proper medical supervision comes in or at least guidance from a person who has a good understanding of the method. In short, it is important not to embark on an intermittent fasting regimen alone without an adequate knowledge of the subject.

This story was published via AFP Relaxnews. (Hero and featured image credit:Louis Hansel @shotsoflouis on Unsplash)

See the original post here:
Are you doing intermittent fasting right? It could lead to weight gain - Lifestyle Asia

Read More..

I reconnected with a friend who became a civil engineer and his area of expertise is traffic flow. He says that people get in trouble at work for going onto a game website and solving logic problems and stuff when in reality he is paid to solve puzzles.

When he started to wax poetic about roundabouts I tried to change the subject by complaining about the timing of traffic lights, a complaint he must hear often because he had a well-prepared and thought out answer.

He said, Traffic lights are designed to carry you along arterial roads, main thoroughfares, with only having to stop once, at the beginning of your journey. If you go the prescribed speed limit then you can by design follow the arterial without stopping until you want to exit. The traffic control lights are where veins, secondary streets, want to join the arterial. Once you are allowed on an arterial from a vein you will have to stop once more, but that is it. The problem arises when people drive too fast. When people drive too fast they clog up sections of the arterial and then there is too much traffic in a section to move efficiently and then they get caught in the timing of the light. Speeders race to the next light and have to stop because they arrive before it has had a chance to turn green.

I asked what constitutes speeding. Anything more than two miles an hour over the prescribed speed limit.

His answer was well thought out and reasoned perfectly, but I didnt exactly like it. I wanted to blame a bureaucracy for random pettiness interfering with my freedom of mobility. He blamed me and my behavior.

He went on, Think about it. Why would we want to create a system that made things worse and made people mad at us? Why would we want to make it more difficult for you to get to work or your favorite restaurant or for an emergency vehicle to get to a scene? We design these things for the most efficient flow of traffic, but that only works if everyone goes along with the plan. People take the lights personally. People hurry to slowness. What can you do?

People hurry to slowness. Huh? It is funny how someone will pass you in a city and you will catch up with them at a light. They will charge ahead when it turns green and you will catch up with them at the next light. You will follow them into the parking lot and they will search for the closest space while you simply grab the first available spot, park, and walk into the store ahead of them.

By the way, I think people trying to park closest in the fitness center parking lot is one of the most hilarious things. I am here to exercise. The last thing in the world I want to do is take 20 extra steps!

But my friends answer made me realize something about me. I didnt like his answer because it meant I would have to change my behavior. I am that way about a lot of things and it probably makes me normal.

If I want to drive more quickly through traffic I need to drive the speed limit. Ughhh! If I want to lose weight and get in shape I need to change my eating and activity habits. What, no pill? If I want to score better in bowling I need to practice and do my muscle drills and keep proper form. A new bowling ball wont fix it? If I am at odds with an important person in my life I need to become sensitive to what they are thinking and feeling. You mean they arent going to change? If I want to sleep at night I need to not have any blue light two hours before I go to bed. So I cannot take my smartphone to bed with me?

I wonder how many problems go unsolved because the answer is simply to change behavior. It costs nothing, it often saves money, we become a better and healthier person by doing it, but it gets back to Adams sin. The first thing Adam did when confronted by God was to say, The woman you gave me . . . Adam is saying that it was not his behavior but Eves and Gods that caused the problem.

The problem with sin is that I want everything wrong in my life to be the rest of the worlds fault. And I want the whole world to change and then I want to take a pill to make it right. God forbid I would have to change my behavior.

Read the original post:
Words to Live By: It's all about changing behavior - Ashland Daily Press

Read More..

Contact Us Today

Page 722«..1020..721722723724..730740..»

Home » Page 722